Journal for ImmunoTherapy of Cancer (Nov 2023)

298 A miRNA-based shRNA platform for the easy, safe, and effective generation of allogeneic CAR T-cells

Thủy Nguyễn,
Matteo Rossi,
Eytan Breman,
Fanny Huberty,
Celine Jacques-Hespel,
Jerome Marijsse

Affiliations

Thủy Nguyễn: Celyad Oncology, Mont-Saint-Guibert, Belgium
Matteo Rossi: Celyad Oncology, Mont-Saint-Guibert, Belgium
Eytan Breman: Celyad Oncology, Mont-Saint-Guibert, Belgium
Fanny Huberty: Celyad Oncology, Mont-Saint-Guibert, Belgium
Celine Jacques-Hespel: Celyad Oncology, Mont-Saint-Guibert, Belgium
Jerome Marijsse: Celyad Oncology, Mont-Saint-Guibert, Belgium

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.0298
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal